echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > The Safety of Lurasidone

    The Safety of Lurasidone

    • Last Update: 2023-05-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Lurasidone is a atypical antipsychotic medication that is commonly used to treat schizophrenia and bipolar disorder.
    It belongs to a class of drugs known as benzisoxazepines, and it works by blocking the action of dopamine in the brain.
    Lurasidone is known for its high potency and long half-life, which makes it effective in treating these conditions, but it also means that it can have potential side effects.


    Safety concerns with Lurasidone


    1. Cardiac issues: Lurasidone has been associated with an increased risk of cardiac arrhythmias, particularly in elderly patients and in those with a history of heart problems.
      The risk of cardiac issues can be reduced by monitoring heart function and taking other precautions, but it remains a concern for patients taking the medication.
    2. Metabolic issues: Lurasidone can cause changes in glucose metabolism, which can lead to an increased risk of developing diabetes.
      Regular monitoring of blood sugar levels is important for patients taking Lurasidone to prevent the onset of diabetes or other metabolic disorders.
    3. Weight gain: Lurasidone can cause significant weight gain, which can increase the risk of other health problems such as obesity, diabetes, and cardiovascular disease.
    4. Neurological issues: Lurasidone can cause extrapyramidal effects such as dystonia, akathisia, and dyskinesia, which can be uncomfortable and disabling.
      These effects can be managed with medication, but they can be severe in some cases.
    5. Falls: Lurasidone can cause dizziness and somnolence, which can increase the risk of falls in elderly patients and those with mobility issues.
    6. Interaction with other drugs: Lurasidone can interact with other drugs, including some antidepressants, antiarrhythmic drugs, and medications used to treat Parkinson's disease.
      This can increase the risk of adverse effects and reduce the effectiveness of the medication.
    7. Long half-life: Lurasidone has a long half-life, which means that it stays in the body for a long time after the medication has been taken.
      This can lead to a buildup of the medication in the body, which can cause adverse effects, particularly if the medication is stopped abruptly.

    Measures to reduce risk


    1. Monitoring: Regular monitoring of heart function, glucose levels, and weight can help to identify any potential side effects early and prevent them from becoming more severe.
    2. Dose adjustment: The manufacturer recommends a lower starting dose for patients with a history of heart problems or who are taking other medications that can affect heart rhythm.
    3. Patient education: Patients taking Lurasidone should be educ
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.